Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hikaru Amamiya"'
Autor:
Mitsuo Obana, Masaaki Miyakawa, Fuyuki Minagawa, Tetsurou Takuma, Atsuko Mokubo, Takehiro Kawata, Akira Kubota, Mizuki Kaneshiro, Yasuo Terauchi, Hajime Maeda, Kotaro Iemitsu, Yasushi Tanaka, Akira Kanamori, Masao Toyoda, Ikuro Matsuba, Hikaru Amamiya, Hiroshi Takeda, Masahiko Takai, Yoshikazu Naka, Hideaki Kaneshige, Daisuke Suzuki, Hideo Machimura, Masashi Ishikawa
Publikováno v:
Diabetology International. 5:98-104
Our goal was to evaluate liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in monotherapy and combination therapy for Japanese type 2 diabetes patients. Patients with type 2 diabetes (111 men, 83 women; mean age 57.6 ± 12.6 years) wer
Autor:
Hajime Maeda, Yasushi Tanaka, Masashi Ishikawa, Shin Honda, Tetsuya Motomiya, Ikuro Matsuba, Takehiro Kawata, Hideo Machimura, Kotaro Iemitsu, Atsuko Mokubo, Tetsuro Takuma, Hideaki Kaneshige, Akira Kanamori, Yasuyuki Jin, Kazuhiko Hoshino, Nobuaki Minami, Yasuo Terauchi, Mizuki Kaneshiro, Hikaru Amamiya, Nobuo Sasai, Yoshikazu Naka, Hiroshi Takeda, Shogo Ito, Akira Kubota, Kiyokazu Matoba, Sachio Aoyagi, Fuyuki Minagawa, Masahiko Takai, Manabu Waseda, Mitsuo Obana
Publikováno v:
Journal of Diabetes Investigation. 3:503-509
(J Diabetes Invest, doi: 10.1111/j.2040-1124.2012.00221.x, 2012) Aims/Introduction: To determine the efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients after 3 months’ therapy. Materials and
Autor:
Yasuyuki Jin, Kazuhiko Hoshino, Tetsuro Takuma, Masahiko Takai, Mizuki Kaneshiro, Masashi Ishikawa, Hideaki Kaneshige, Manabu Waseda, Mitsuo Obana, Shin Honda, Sachio Aoyagi, Hideo Machimura, Nobuaki Minami, Akira Kubota, Tetsuya Motomiya, Nobuo Sasai, Kotaro Iemitsu, Yukiko Miyairi, Hiroshi Takeda, Yasuo Terauchi, Shogo Ito, Atsuko Mokubo, Hajime Maeda, Yoshikazu Naka, Takehiro Kawata, Akira Kanamori, Kiyokazu Matoba, Hikaru Amamiya, Shinichi Umezawa, Fuyuki Minagawa, Yasushi Tanaka, Ikuro Matsuba
Publikováno v:
BMC Endocrine Disorders
Background There have only been a few reports about use of dipeptidyl peptidase 4 (DPP-4) inhibitors in elderly patients with type 2 diabetes mellitus (T2DM), suggesting that the safety of these agents has not been sufficiently demonstrated. We perfo
Autor:
Fuyuki Minagawa, Atsuko Mokubo, Masaaki Miyakawa, Masashi Ishikawa, Hideaki Kaneshige, Hiroshi Takeda, Yasushi Tanaka, Kotaro Iemitsu, Tetsurou Takuma, Yasuo Terauchi, Hajime Maeda, Ikuro Matsuba, Hideo Machimura, Mizuki Kaneshiro, Akira Kanamori, Hikaru Amamiya, Masahiko Takai, Akira Kubota, Masao Toyoda, Mitsuo Obana, Daisuke Suzuki, Takehiro Kawata, Yoshikazu Naka
Publikováno v:
Journal of Clinical Medicine Research
Background : To evaluate the efficacy of switching from insulin to the GLP-1 receptor agonist liraglutide in type 2 diabetes mellitus patients. Methods : The subjects were 231 outpatients with type 2 diabetes mellitus being treated with liraglutide f
Autor:
Shinichi Umezawa, Akira Kubota, Hajime Maeda, Akira Kanamori, Kiyokazu Matoba, Yasuyuki Jin, Fuyuki Minagawa, Mitsuo Obana, Kotaro Iemitsu, Shogo Ito, Hikaru Amamiya, Mizuki Kaneshiro, Masahiko Takai, Hideaki Kaneshige, Kazuhiko Hoshino, Masashi Ishikawa, Nobuaki Minami, Tetsuro Takuma, Nobuo Sasai, Sachio Aoyagi
Publikováno v:
BMC Endocrine Disorders; Jul2015, Vol. 15 Issue 1, p1-8, 8p, 4 Charts, 6 Graphs